1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NEULAND LABORATORIES LTD.

Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558

Falling Comet
Download real time

11192.00 128.00 (1.16%)

38.17% Fall from 52W High

65,591 NSE+BSE Volume

NSE 29 May, 2025 3:03 PM (IST)

Watchlist

Portfolio

Alert

Share
14S
12W
6O
1T
14,359.2

Market Cap

High in industry
55.2

PE TTM

Above industry Median
-4.1

PEG TTM

PEG TTM is negative
10.3

Price to Book

High in industry
0.8

Beta 1Year

Very Low volatility

Analyze undervaluation/ overvaluation of Neuland Laboratories Ltd. with current and 1 Year Forward PE

INSIGHT
Neuland Laboratories Ltd. is overvalued at current PE, but fairly valued on future earnings estimates
Right Now : Current PE vs 5 year Average PE
Overvalued
Fair price

Based on 5Yr Average PE

7148.4
Upside

Current PE versus 5Yr Average PE

-36.13 %
1 Year Forward : 5 Yr Average PE & Projected 1Yr Forward EPS*
Overvalued
Fair price

Based on 1Yr Forward EPS

9540.6
Upside

5 Yr Average PE & 1Yr Forward EPS

-14.76 %
Info: The Neuland Laboratories Ltd.'s current PE is 55.20 ,while its 5 year PE average is 35.3. Its forward PE based on analyst estimates is 41.4
Note: The forward P/E ratio (or forward price-to-earnings ratio) is calculated by dividing the current share price of a company by the estimated(1Yr) future (“forward”) earnings per share (EPS) of that company.
generated report

Analyze undervaluation/ overvaluation of Neuland Laboratories Ltd. with historical PE and PBV ratios

Need Help?

from 29 May, 2023 to 28 May, 2025

Standalone P/E

Strong Sell Zone

82.7% into P/E buy sell zone

% time spent below current P/E
0 20 40 60 80 100
Strong upside potential
Gains already realized

Out of 496 days, Neuland Laboratories Ltd. traded 410 (82.7%) days below the current P/E of on Standalone basis.

Consolidated P/E

Strong Sell Zone

82.7% into P/E buy sell zone

% time spent below current P/E
0 20 40 60 80 100
Strong upside potential
Gains already realized

Out of 496 days, Neuland Laboratories Ltd. traded 410 (82.7%) days below the current P/E of on Consolidated basis.

Note: This is a reverse percentile score. Values close to 100% are bad while values close to 0% are good. Days when PE is negative are not considered in the analysis
82.7%

Strong Sell Zone

% Days traded below current P/E

55.2
 

Current P/E

38.5
 

Average P/E

30.0
 

Median P/E

9540.6
 

Forward 1Y Price

41.4
 

Forward PE

270.6
 

Forward EPS

P/E range Days traded in range % Days traded in range Days traded within & below range % Days traded within & below range
20-23
 56 11.3% 56 11.3%
23-25
 65 13.1% 121 24.4%
25-27
 73 14.7% 194 39.1%
27-30
 56 11.3% 250 50.4%
30-48
Forward PE is 41.36 		85 17.1% 335 67.5%
48-54
 62 12.5% 397 80.0%
54-64
Current P/E is 55.2 		57 11.5% 454 91.5%
64-83
 42 8.5% 496 100.0%
Total 496 496
82.7%

Strong Sell Zone

% Days traded below current P/E

55.4
 

Current P/E

38.5
 

Average P/E

30.0
 

Median P/E

9540.6
 

Forward 1Y Price

41.4
 

Forward PE

270.6
 

Forward EPS

P/E range Days traded in range % Days traded in range Days traded within & below range % Days traded within & below range
20-23
 54 10.9% 54 10.9%
23-25
 68 13.7% 122 24.6%
25-27
 71 14.3% 193 38.9%
27-30
 56 11.3% 249 50.2%
30-48
Forward PE is 41.36 		82 16.5% 331 66.7%
48-54
 66 13.3% 397 80.0%
54-64
Current P/E is 55.4 		53 10.7% 450 90.7%
64-83
 46 9.3% 496 100.0%
Total 496 496

FAQ

  • What is the PE ratio?

    In its simplest definition, the price-to-earnings ratio (P/E ratio) represents the price an investor pays per rupee of a company's earnings.
    For example, if a company has a P/E ratio of 25, investors are willing to pay INR 25 for each rupee of the company's current earnings. This indicates that investors value the stock at 25 times its current earnings, with an expectation of future earnings growth.
    The P/E ratio fluctuates based on investor sentiment towards a company. Positive sentiment drives the stock price higher, resulting in a higher P/E ratio (investors pay more for each rupee of earnings). Conversely, negative sentiment lowers the P/E ratio (investors pay less for each rupee of earnings).

  • What is the PE buy/sell zone?

    The PE buy/sell zone is calculated based on how many days a stock has traded at its current PE level.
    To do this, we compare the current PE to the stock’s historical PE performance, to find out how often (for how many days in the past) the stock has traded at its current PE value.
    If the stock has usually traded above its current PE level (it’s at a higher PE for the majority of trading days), then the stock is cheaper than usual and in the PE buy zone.
    If the stock has usually traded below its current PE level (it’s at a lower PE for the majority of trading days), then the stock is more expensive than usual and in the PE sell zone.

  • How is the PE buy sell zone useful?

    The PE buy sell zone tells you if a stock’s current PE level is unusually high or low, and if a stock doesn’t typically trade at that level. It helps investors identify stocks that are undervalued or overvalued in terms of their typical PE trading behavior.
    Investors should keep in mind that the buy zone/sell zone is not a foolproof buy or sell signal. For example, the PE of a stock may have fallen substantially due to adverse events or negative news. Or the PE may have risen sharply after the company has won new orders, made an acquisition, announced a buyback, or some other positive event. PE Buy/Sell Zone signals should be looked at in conjunction with other information.

  • Why are the number of days different for Standalone and Consolidated data?

    This can be because of any of the 2 following reasons:
    1. Days when PE is negative are not considered in the analysis. So if only 1 of the Standalone or Consolidated PE is negative and the other is not, then the days will be different
    2. Companies have reported Consolidated data for limited period.
Buy Sell Stock Screeners